The problem with IV dosage form is that remdesivir is practically insoluble in water and requires an auxiliary solvent in its formulation
Nature 378 , 776779
Jimnez-Fernndez S, Gurpegui M, Garrote-Rojas D, Gutirrez-Rojas L, Carretero MD, Correll CU
1 In the REIMAGINE 2 trial, the most commonly reported AEs were GI-related, occurring in 405/603 (67.2%) participants in the CagriSema 2.4 mg/2.4 mg group, 326/605 (53.9%) participants in the semaglutide 2.4 mg group, 60/152 (39.5%) participants in the cagrilintide 2.4 mg group, 329/594 (55.4%) participants in the CagriSema 1 mg/1 mg group, 288/608 (47.4%) participants in the semaglutide 1 mg group, and 42/149 (28.2%) participants in the placebo group
Concordance with the Sanger method was lower for HCV genotype 2, 4 and 6 subtypes than for HCV genotype 1 and 3 and 5 subtypes (Table 3)
Immunoblotting confirmed the existence of frameshift mutations at the target site and the absence of the corresponding full-length proteins (Fig
